- Home
- / LegoChem Biosciences
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
LegoChem Biosciences financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
₩127.2 K
2024-10-28
Market Capitalization
₩4.8 T
2024-10-28
Revenue
₩141.6 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| KRW | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 25.2B | 57.5B | 49.4B | 32.2B | 33.4B | 34.1B | 125.9B | 141.6B |
| Cost of goods sold | 7.9B | 12.8B | 7.7B | 11.7B | 8.5B | 13.4B | 12.8B | 11.4B |
| Gross profit | 18.1B | 48.8B | 62.3B | 23.5B | 25.4B | 21.0B | 113.1B | 130.4B |
| Gross profit margin, % | 71.6% | 84.9% | 126.2% | 73.2% | 75.9% | 61.5% | 89.9% | 92.1% |
| Operating expense total | 30.6B | 32.5B | 68.5B | 48.2B | 61.4B | 96.9B | 129.0B | 230.0B |
| Depreciation and amortization | 14.2B | 3.9B | 3.0B | 4.4B | 4.9B | 5.0B | 6.6B | |
| EBITDA | (12.5B) | 16.3B | (4.7B) | (23.7B) | (36.0B) | (75.0B) | (15.0B) | (98.4B) |
| EBITDA margin, % | -49.5% | 28.4% | -9.5% | -73.6% | -107.6% | -219.7% | -11.9% | -69.5% |
| EBIT | (26.7B) | 12.2B | (9.3B) | (23.5B) | (50.2B) | (80.0B) | (20.0B) | (105.1B) |
| EBIT margin, % | -105.9% | 21.2% | -18.7% | -73.2% | -150.2% | -234.2% | -15.9% | -74.2% |
| Interest income | 425.0M | 1.5B | 1.0B | 901.3M | 4.3B | 5.8B | 20.0B | 18.4B |
| Interest expense | 125.7M | 25.8M | 68.8M | 285.8M | 528.3M | 503.2M | 883.2M | |
| Pre tax profit | (26.4B) | 13.1B | (8.8B) | (20.5B) | (47.7B) | (75.7B) | 9.1B | (93.8B) |
| Income tax expense | (354.1M) | 626.0M | (1.8B) | 2.9B | (2.6B) | (2.0B) | 1.3B | (2.3B) |
| Net Income | (26.1B) | 12.5B | (7.0B) | (23.4B) | (45.1B) | (73.7B) | 7.8B | (91.5B) |